Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Low-frequency parietal repetitive transcranial magnetic stimulation reduces fear and anxiety.

Balderston NL, Beydler EM, Goodwin M, Deng ZD, Radman T, Luber B, Lisanby SH, Ernst M, Grillon C.

Transl Psychiatry. 2020 Feb 17;10(1):68. doi: 10.1038/s41398-020-0751-8.

PMID:
32066739
2.

Using Transcranial Magnetic Stimulation to Test a Network Model of Perceptual Decision Making in the Human Brain.

Luber B, Jangraw DC, Appelbaum G, Harrison A, Hilbig S, Beynel L, Jones T, Sajda P, Lisanby SH.

Front Hum Neurosci. 2020 Jan 24;14:4. doi: 10.3389/fnhum.2020.00004. eCollection 2020.

3.

Device-Based Modulation of Neurocircuits as a Therapeutic for Psychiatric Disorders.

Deng ZD, Luber B, Balderston NL, Velez Afanador M, Noh MM, Thomas J, Altekruse WC, Exley SL, Awasthi S, Lisanby SH.

Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:591-614. doi: 10.1146/annurev-pharmtox-010919-023253.

PMID:
31914895
4.

Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects.

Balderston NL, Beydler EM, Roberts C, Deng ZD, Radman T, Lago T, Luber B, Lisanby SH, Ernst M, Grillon C.

Neuropsychopharmacology. 2020 Mar;45(4):694-702. doi: 10.1038/s41386-019-0583-5. Epub 2019 Dec 2.

5.

Theta Burst for Cognitive Remediation in Schizophrenia: A Case Series and Feasibility Study.

Rakesh G, Mischel NA, Luber B, Keefe RSE, Emory S, Lisanby SH, Szabo ST.

J ECT. 2020 Mar;36(1):72-74. doi: 10.1097/YCT.0000000000000625. No abstract available.

PMID:
31652174
6.

MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells.

Ebert K, Mattes J, Kunzke T, Zwingenberger G, Luber B.

PLoS One. 2019 Sep 26;14(9):e0223225. doi: 10.1371/journal.pone.0223225. eCollection 2019.

7.

Effects of online repetitive transcranial magnetic stimulation (rTMS) on cognitive processing: A meta-analysis and recommendations for future studies.

Beynel L, Appelbaum LG, Luber B, Crowell CA, Hilbig SA, Lim W, Nguyen D, Chrapliwy NA, Davis SW, Cabeza R, Lisanby SH, Deng ZD.

Neurosci Biobehav Rev. 2019 Dec;107:47-58. doi: 10.1016/j.neubiorev.2019.08.018. Epub 2019 Aug 29. Review.

8.

Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy.

Llosa NJ, Luber B, Siegel N, Awan AH, Oke T, Zhu Q, Bartlett BR, Aulakh LK, Thompson ED, Jaffee EM, Durham JN, Sears CL, Le DT, Diaz LA Jr, Pardoll DM, Wang H, Housseau F, Anders RA.

Cancer Immunol Res. 2019 Oct;7(10):1574-1579. doi: 10.1158/2326-6066.CIR-18-0927. Epub 2019 Aug 22.

PMID:
31439614
9.

Accuracy of robotic coil positioning during transcranial magnetic stimulation.

Goetz SM, Kozyrkov IC, Luber B, Lisanby SH, Murphy DLK, Grill WM, Peterchev AV.

J Neural Eng. 2019 Sep 17;16(5):054003. doi: 10.1088/1741-2552/ab2953.

PMID:
31189147
10.

Multimodal analysis of formalin-fixed and paraffin-embedded tissue by MALDI imaging and fluorescence in situ hybridization for combined genetic and metabolic analysis.

Huber K, Kunzke T, Buck A, Langer R, Luber B, Feuchtinger A, Walch A.

Lab Invest. 2019 Oct;99(10):1535-1546. doi: 10.1038/s41374-019-0268-z. Epub 2019 May 31.

PMID:
31148595
11.

Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors.

Llosa NJ, Luber B, Tam AJ, Smith KN, Siegel N, Awan AH, Fan H, Oke T, Zhang J, Domingue J, Engle EL, Roberts CA, Bartlett BR, Aulakh LK, Thompson ED, Taube JM, Durham JN, Sears CL, Le DT, Diaz LA, Pardoll DM, Wang H, Anders RA, Housseau F.

Clin Cancer Res. 2019 Sep 1;25(17):5250-5259. doi: 10.1158/1078-0432.CCR-19-0114. Epub 2019 May 6.

PMID:
31061070
12.

Online repetitive transcranial magnetic stimulation during working memory in younger and older adults: A randomized within-subject comparison.

Beynel L, Davis SW, Crowell CA, Hilbig SA, Lim W, Nguyen D, Palmer H, Brito A, Peterchev AV, Luber B, Lisanby SH, Cabeza R, Appelbaum LG.

PLoS One. 2019 Mar 22;14(3):e0213707. doi: 10.1371/journal.pone.0213707. eCollection 2019.

13.

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA Jr, Brahmer JR, Pardoll DM, Anders RA, Housseau F.

J Immunother Cancer. 2019 Mar 6;7(1):63. doi: 10.1186/s40425-019-0547-7.

14.

Low- and High-Frequency Repetitive Transcranial Magnetic Stimulation Effects on Resting-State Functional Connectivity Between the Postcentral Gyrus and the Insula.

Addicott MA, Luber B, Nguyen D, Palmer H, Lisanby SH, Appelbaum LG.

Brain Connect. 2019 May;9(4):322-328. doi: 10.1089/brain.2018.0652. Epub 2019 Apr 2.

PMID:
30773890
15.

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA Jr, Brahmer JR, Pardoll DM, Anders RA, Housseau F.

J Immunother Cancer. 2019 Feb 11;7(1):40. doi: 10.1186/s40425-018-0492-x. Erratum in: J Immunother Cancer. 2019 Mar 6;7(1):63.

16.

Enhancing activation in the right temporoparietal junction using theta-burst stimulation: Disambiguating between two hypotheses of top-down control of behavioral mimicry.

Duffy KA, Luber B, Adcock RA, Chartrand TL.

PLoS One. 2019 Jan 25;14(1):e0211279. doi: 10.1371/journal.pone.0211279. eCollection 2019.

17.

Complementary topology of maintenance and manipulation brain networks in working memory.

Davis SW, Crowell CA, Beynel L, Deng L, Lakhlani D, Hilbig SA, Lim W, Nguyen D, Peterchev AV, Luber BM, Lisanby SH, Appelbaum LG, Cabeza R.

Sci Rep. 2018 Dec 13;8(1):17827. doi: 10.1038/s41598-018-35887-2.

18.

The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions.

Sathappan AV, Luber BM, Lisanby SH.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:347-360. doi: 10.1016/j.pnpbp.2018.10.006. Epub 2018 Oct 9. Review.

PMID:
30312634
19.

On the Concurrent Use of Self-System Therapy and Functional Magnetic Resonance Imaging-Guided Transcranial Magnetic Stimulation as Treatment for Depression.

Neacsiu AD, Luber BM, Davis SW, Bernhardt E, Strauman TJ, Lisanby SH.

J ECT. 2018 Dec;34(4):266-273. doi: 10.1097/YCT.0000000000000545.

20.

Excitatory TMS modulates memory representations.

Wang WC, Wing EA, Murphy DLK, Luber BM, Lisanby SH, Cabeza R, Davis SW.

Cogn Neurosci. 2018 Jul - Oct;9(3-4):151-166. doi: 10.1080/17588928.2018.1512482. Epub 2018 Sep 5.

21.

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting.

Rowe SP, Luber B, Makell M, Brothers P, Santmyer J, Schollenberger MD, Quinn H, Edelstein DL, Jones FS, Bleich KB, Sharfman WH, Lipson EJ.

Mol Oncol. 2018 Oct;12(10):1661-1672. doi: 10.1002/1878-0261.12373. Epub 2018 Sep 8.

22.

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.

Boudadi K, Suzman DL, Anagnostou V, Fu W, Luber B, Wang H, Niknafs N, White JR, Silberstein JL, Sullivan R, Dowling D, Harb R, Nirschl TR, Veeneman BA, Tomlins SA, Wang Y, Jendrisak A, Graf RP, Dittamore R, Carducci MA, Eisenberger MA, Haffner MC, Meeker AK, Eshleman JR, Luo J, Velculescu VE, Drake CG, Antonarakis ES.

Oncotarget. 2018 Jun 19;9(47):28561-28571. doi: 10.18632/oncotarget.25564. eCollection 2018 Jun 19.

23.

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.

Antonarakis ES, Lu C, Luber B, Liang C, Wang H, Chen Y, Silberstein JL, Piana D, Lai Z, Chen Y, Isaacs WB, Luo J.

Eur Urol. 2018 Aug;74(2):218-225. doi: 10.1016/j.eururo.2018.01.035. Epub 2018 Feb 10.

24.

Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.

Keller S, Zwingenberger G, Ebert K, Hasenauer J, Wasmuth J, Maier D, Haffner I, Schierle K, Weirich G, Luber B.

Mol Oncol. 2018 Apr;12(4):441-462. doi: 10.1002/1878-0261.12170. Epub 2018 Mar 10.

25.

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.

Teply BA, Wang H, Luber B, Sullivan R, Rifkind I, Bruns A, Spitz A, DeCarli M, Sinibaldi V, Pratz CF, Lu C, Silberstein JL, Luo J, Schweizer MT, Drake CG, Carducci MA, Paller CJ, Antonarakis ES, Eisenberger MA, Denmeade SR.

Lancet Oncol. 2018 Jan;19(1):76-86. doi: 10.1016/S1470-2045(17)30906-3. Epub 2017 Dec 14.

26.

Differences in Seizure Expression Between Magnetic Seizure Therapy and Electroconvulsive Shock.

Cycowicz YM, Rowny SB, Luber B, Lisanby SH.

J ECT. 2018 Jun;34(2):95-103. doi: 10.1097/YCT.0000000000000470.

PMID:
29240021
27.

Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.

Keller S, Kneissl J, Grabher-Meier V, Heindl S, Hasenauer J, Maier D, Mattes J, Winter P, Luber B.

BMC Cancer. 2017 Dec 13;17(1):845. doi: 10.1186/s12885-017-3822-3.

28.

PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI.

Urban C, Buck A, Siveke JT, Lordick F, Luber B, Walch A, Aichler M.

Biochim Biophys Acta Gen Subj. 2018 Jan;1862(1):51-60. doi: 10.1016/j.bbagen.2017.10.005. Epub 2017 Oct 9.

PMID:
29024724
29.

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome.

Kunzke T, Balluff B, Feuchtinger A, Buck A, Langer R, Luber B, Lordick F, Zitzelsberger H, Aichler M, Walch A.

Oncotarget. 2017 Jul 10;8(40):68012-68025. doi: 10.18632/oncotarget.19137. eCollection 2017 Sep 15.

30.

Frequency-specific neuromodulation of local and distant connectivity in aging and episodic memory function.

Davis SW, Luber B, Murphy DLK, Lisanby SH, Cabeza R.

Hum Brain Mapp. 2017 Dec;38(12):5987-6004. doi: 10.1002/hbm.23803. Epub 2017 Sep 8.

31.

Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.

Llosa NJ, Cooke KR, Chen AR, Gamper CJ, Klein OR, Zambidis ET, Luber B, Rosner G, Siegel N, Holuba MJ, Robey N, Hayashi M, Jones RJ, Fuchs E, Holdhoff M, Loeb DM, Symons HJ.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2127-2136. doi: 10.1016/j.bbmt.2017.08.012. Epub 2017 Aug 12.

33.

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr.

Science. 2017 Jul 28;357(6349):409-413. doi: 10.1126/science.aan6733. Epub 2017 Jun 8.

34.

Reprint of ''Using neuroimaging to individualize TMS treatment for depression: Toward a new paradigm for imaging-guided intervention''.

Luber BM, Davis S, Bernhardt E, Neacsiu A, Kwapil L, Lisanby SH, Strauman TJ.

Neuroimage. 2017 May 1;151:65-71. doi: 10.1016/j.neuroimage.2017.03.049.

PMID:
28476213
35.

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Zhu Y, Silberstein JL, Taylor MN, Maughan BL, Denmeade SR, Pienta KJ, Paller CJ, Carducci MA, Eisenberger MA, Luo J.

J Clin Oncol. 2017 Jul 1;35(19):2149-2156. doi: 10.1200/JCO.2016.70.1961. Epub 2017 Apr 6.

36.

Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability.

O JH, Jacene H, Luber B, Wang H, Huynh MH, Leal JP, Wahl RL.

J Nucl Med. 2017 Sep;58(9):1429-1434. doi: 10.2967/jnumed.117.189605. Epub 2017 Mar 30.

37.

Using neuroimaging to individualize TMS treatment for depression: Toward a new paradigm for imaging-guided intervention.

Luber BM, Davis S, Bernhardt E, Neacsiu A, Kwapil L, Lisanby SH, Strauman TJ.

Neuroimage. 2017 Mar 1;148:1-7. doi: 10.1016/j.neuroimage.2016.12.083. Epub 2017 Jan 3. Review.

38.

Pulse Width Affects Scalp Sensation of Transcranial Magnetic Stimulation.

Peterchev AV, Luber B, Westin GG, Lisanby SH.

Brain Stimul. 2017 Jan - Feb;10(1):99-105. doi: 10.1016/j.brs.2016.09.007. Epub 2016 Oct 6.

39.

Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, Zwingenberger G, Weichert W, Luber B.

J Cancer Res Clin Oncol. 2017 Apr;143(4):573-600. doi: 10.1007/s00432-016-2308-z. Epub 2016 Dec 8.

40.

Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria.

Gunn AJ, Sheth RA, Luber B, Huynh MH, Rachamreddy NR, Kalva SP.

Cardiovasc Intervent Radiol. 2017 Jan;40(1):61-68. doi: 10.1007/s00270-016-1451-x. Epub 2016 Nov 10.

PMID:
27834009
41.

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.

Maughan BL, Suzman DL, Luber B, Wang H, Glavaris S, Hughes R, Sullivan R, Harb R, Boudadi K, Paller C, Eisenberger M, Demarzo A, Ross A, Antonarakis ES.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1297-1304. doi: 10.1007/s00280-016-3191-7. Epub 2016 Nov 8.

42.

Deriving frequency-dependent spatial patterns in MEG-derived resting state sensorimotor network: A novel multiband ICA technique.

Nugent AC, Luber B, Carver FW, Robinson SE, Coppola R, Zarate CA Jr.

Hum Brain Mapp. 2017 Feb;38(2):779-791. doi: 10.1002/hbm.23417. Epub 2016 Oct 22.

43.

Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.

Maughan BL, Luber B, Nadal R, Antonarakis ES.

Prostate. 2017 Jan;77(1):33-40. doi: 10.1002/pros.23246. Epub 2016 Aug 16.

PMID:
27527643
44.

Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.

Schweizer MT, Wang H, Luber B, Nadal R, Spitz A, Rosen DM, Cao H, Antonarakis ES, Eisenberger MA, Carducci MA, Paller C, Denmeade SR.

Prostate. 2016 Sep;76(13):1218-26. doi: 10.1002/pros.23209. Epub 2016 Jun 24.

PMID:
27338150
45.

Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.

Sadtler K, Estrellas K, Allen BW, Wolf MT, Fan H, Tam AJ, Patel CH, Luber BS, Wang H, Wagner KR, Powell JD, Housseau F, Pardoll DM, Elisseeff JH.

Science. 2016 Apr 15;352(6283):366-70. doi: 10.1126/science.aad9272.

46.

Group sequential designs with prospectively planned rules for subpopulation enrichment.

Rosenblum M, Luber B, Thompson RE, Hanley D.

Stat Med. 2016 Sep 20;35(21):3776-91. doi: 10.1002/sim.6957. Epub 2016 Apr 13.

PMID:
27076411
47.

Skilled Bimanual Training Drives Motor Cortex Plasticity in Children With Unilateral Cerebral Palsy.

Friel KM, Kuo HC, Fuller J, Ferre CL, Brandão M, Carmel JB, Bleyenheuft Y, Gowatsky JL, Stanford AD, Rowny SB, Luber B, Bassi B, Murphy DL, Lisanby SH, Gordon AM.

Neurorehabil Neural Repair. 2016 Oct;30(9):834-44. doi: 10.1177/1545968315625838. Epub 2016 Feb 11.

48.

The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer.

Teply BA, Luber B, Denmeade SR, Antonarakis ES.

Prostate Cancer Prostatic Dis. 2016 Mar;19(1):72-8. doi: 10.1038/pcan.2015.53. Epub 2015 Nov 17.

49.

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Hyun O J, Luber BS, Leal JP, Wang H, Bolejack V, Schuetze SM, Schwartz LH, Helman LJ, Reinke D, Baker LH, Wahl RL.

J Nucl Med. 2016 May;57(5):735-40. doi: 10.2967/jnumed.115.162412. Epub 2016 Jan 21.

50.

Enhancement of Neuromodulation with Novel Pulse Shapes Generated by Controllable Pulse Parameter Transcranial Magnetic Stimulation.

Goetz SM, Luber B, Lisanby SH, Murphy DL, Kozyrkov IC, Grill WM, Peterchev AV.

Brain Stimul. 2016 Jan-Feb;9(1):39-47. doi: 10.1016/j.brs.2015.08.013. Epub 2015 Sep 1.

Supplemental Content

Support Center